Profit Margin (Quarterly)

Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues

CorMedix Inc (CRMD) had Profit Margin of 25.50% for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$101.93M
Net Income	$25.99M
Cost of Goods Sold	$24.80M
Gross Profit	$77.13M
Operating Expenses	$59.02M
Operating Income	$42.91M
Non-Operating Income/Expense	$-4.18M
Pre-Tax Income	$38.73M
Normalized Pre-Tax Income	$38.73M
Income after Taxes	$25.99M
Income from Continuous Operations	$25.99M
Consolidated Net Income/Loss	$25.99M
Normalized Income after Taxes	$25.99M
EBIT	$42.91M
EBITDA	$53.45M
Weighted-Average Shares Outstanding (Basic)	78.44M
Weighted-Average Shares Outstanding (Diluted)	92.48M
Earnings per Share (EPS) (Basic)	$0.33
Earnings per Share (EPS) (Diluted)	$0.29
Balance Sheet Financials
Current Assets	$480.55M
Property, Plant, and Equipment	$7.85M
Long-Term Assets	$423.50M
Total Assets	$904.05M
Current Liabilities	$187.40M
Long-Term Debt	$145.15M
Long-Term Liabilities	$255.82M
Total Liabilities	$443.22M
Common Equity	$460.83M
Tangible Shareholders Equity	$72.36M
Shareholders Equity	$460.83M
Common Shares Outstanding	77.67M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$128.62M
Cash Flow from Investing Activities	$2.40M
Cash Flow from Financial Activities	$-19.17M
Beginning Cash	$145.82M
End Cash	$257.68M
Increase/Decrease in Cash	$111.86M
Stock-Based Compensation	$8.67M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.56
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.24
Debt to Equity Ratio	0.32
Gross Margin	75.66%
Operating Margin	42.10%
EBIT Margin	42.10%
EBITDA Margin	--
Pre-Tax Profit Margin	38.00%
Profit Margin	25.50%
Free Cash Flow	$127.33M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.11
Inventory Turnover	0.64
Receiveable Turnover	0.63
Days Sales in Receivables	142.42
Return on Equity	5.64%
Return on Tangible Equity	35.92%
Return on Assets	2.87%
Return on Investments	4.29%
Book Value Per Share	$5.93
Free Cash Flow per Share	$1.38
Operating Cash Flow per Share	$1.39

Data from Zacks Investment Research, Inc.